The hepatitis C virus (HCV) infects hepatocytes after binding to heparan sulfate proteoglycans, in particular Syndecan-1, followed by recognition of the tetraspanin CD81 and other receptors. 
2014; Schulze, Gripon, & Urban, 2007; Shi, Jiang, & Luo, 2013) . Hepatitis C virus (HCV) is a strictly human pathogen acquired by contact with contaminated blood. It exhibits liver tropism, replicates in hepatocytes, and is a major cause of hepatocellular carcinoma. HCV encounters a specific microenvironment in the vicinity of the hepatocyte membrane, where Synd-1 and Synd-4 are found, and enters cells via a complex recognition process involving at least a quartet of receptors including the tetraspanin CD81 (Pileri et al., 1998) , the scavenger receptor B type I (Scarselli et al., 2002) , and the tight junction components claudin-1 and occludin Liu et al., 2009; Ploss et al., 2009 ). However, two main issues remain in our comprehension of the initial stages of HCV infection: (a) most HCV entry factors are ubiquitous and cannot account for its hepatotropism and (b) the link between these factors and molecules of the hepatocyte glycocalyx remains to be determined. Here, we report that HCV infection proceeds through a direct interaction between Synd-1 and CD81 and impacts on the hepatocyte glycocalyx during the viral propagation process.
2 | RESULTS 2.1 | Synd-1 and CD81 colocalize at the hepatocyte basolateral membrane In nonpolarized Huh7.5 cells, Synd-1 signal also coincided partially with CD81, and to a lesser extent with claudin-1, but did not merge with occludin, SR-B1 or the low density lipoprotein receptor ( Figure S1C ). Image correlation analyses (Bolte & Cordelières, 2006) revealed a continuous increase in Synd-1 or CD81 colocalization over 6 days (see also Figure 7a ,c for visualization and quantification).
Because Synd-4 was reported as an HCV entry factor (Lefèvre et al., 2014) , we assessed its localization pattern; in PHH and Huh7.5 cells, 
| HCV infection and the hepatocyte glycocalyx
Cells silenced for Synd-1 were significantly less susceptible to HCV infection than those untreated or transfected with nontargeting small interfering RNAs (siRNAs), with a drop of ≈80% in terms of relative infectivity and HCV RNA levels (Figure 2a HCV RNA levels, 80 ± 5% and 88 ± 3% inhibition were measured, respectively. This inhibition was HCV specific, as silencing of these proteins, alone or together, had an effect on HCV pseudotyped particles (HCVpp) infection, but no effect on vesicular stomatitis virus G protein-pseudotyped particle (VSVGpp) infection ( Figure 2b ).
Importantly, Synd-1 silencing did not influence the expression of the key HCV receptors CD81, SR-BI, claudin-1, and occludin ( Figure S3A , D, not shown), as previously reported (Shi et al., 2013) .
On the basis of colocalization data, we hypothesized that Synd-1 and CD81 would cooperate in HCV infection. We therefore silenced both genes, which resulted in a significantly stronger inhibition of HCV infection than silencing each gene separately ( HCV infection led to the down-regulation of Synd-1 mRNA and protein expression, apparent 5 days post-infection, whereas CD81 levels remained unchanged over the same time (Figures 2d,e, S4).
Claudin-1 and occludin were also down-regulated (Figure 2d ), as already described (Liu et al., 2009; Tscherne et al., 2007) .
One of the main components of HSPG and therefore of Synd-1 biosynthesis is xylose. It is the first sugar attached to specific serine residues of HSPG core proteins by Xylosyltransferase (Xylt) 1 or Xylt 2 activity to yield a tetrasaccharide primer that is further glycosylated, and N-and O-sulfated in the Golgi apparatus (Bishop, Schuksz, & Esko, 2007) . The action of these enzymes is thus rate-limiting, and the whole glycocalyx of a given cell type is shaped by their activity. In the liver, specifically in hepatocytes, Xylt 2 expression is prominent (Pönighaus et al., 2007) . We therefore assessed the silencing of Xylt 2 upon Figure S5C ). Thus, virions might also be trafficking by another pathway than clathrin-dependent endocytosis when they are internalized along with Synd-1.
FIGURE 1 Syndecans (Synd)-1 is localized at the hepatocyte basolateral blood pole. Primary human hepatocytes (PHH) 8 days post-plating (D8 p.p.) or HepG2c-CD81 cells were fixed, stained for Synd-1 or Synd-4 (red), and CD81 (green). Claudin-1 (red) or CD26 (green) was used as apical bile pole markers. Observations were performed with a confocal spectral microscope and Van Steensel's ( Figure S8 ). All modes of calculation pointed to a reduction of Synd-1 or CD81 colocalization upon HCV infection, with a sharp decrease after 6 days. Taken together, our data indicate that Synd-1 plays a role during early and late stages of HCV infection, most likely through its physical interaction with CD81.
| DISCUSSION
Blood-borne hepatotropic viruses cross the space of Disse while leaving the blood stream through the fenestrae of sinusoid capillaries FIGURE 4 Synd-1 and HCV are co-internalized. (a) Huh7.5 cells were incubated at 4°C for 1 hr with JFH-1 HCV (MOI 3), and shifted to 37°C for indicated times. After inoculum removal, cells were fixed and immunostained for HCV core (red) and Synd-1 (green), using appropriate secondary antibodies coupled to Dylight® or AlexaFluor®. Representative images are shown with orthogonal sections, and imaging was performed on a confocal spectral microscope. Bar, 10 μm, (b) same procedure as in A, 90 min post temperature shift. Each separate color channel is shown, (c) Huh7.5 cells were treated with heparinases I, II, and III (Heparinase; David et al., 1992) or not (Control). After washing, cells were placed at 4°C and incubated with JFH-1 HCV (MOI 3) for 1 hr, then shifted to 37°C for 30 min. Immuno-staining was done with monoclonal antibodies C7-50 against HCV core (red), and 3G10 that reacts only with heparinase-treated oligosaccharide chains (HS; green; David et al., 1992) , and (d) The degree of colocalization of HCV particles (core) with Synd-1, at indicated times post-temperature shift, was quantified by determining Pearson's correlation coefficients (Dunn et al., 2011) . Results, mean ± SD (n = 3, 50 cells counted per experiment; ** p < .005 between conditions at 30 min without or with heparinases treatment)
FIGURE 5 Synd-1 and HCV are internalized in endosomal compartments. Huh7.5 cells, transduced with green fluorescent protein-fused Rab5 (green), were inoculated with JFH-1 HCV (MOI 3) for 1 hr at 4°C, then shifted to 37°C for 30 min (a) or 90 min (b). After fixation, cells were labeled for Synd-1 (secondary: AlexaFluor®555; red) and HCV core (secondary: AlexaFluor®647; false color blue), and observed with a confocal spectral microscope. (c) Quantification of the number of triple colocalization events between Synd-1, HCV core, and indicated endosomal markers, counted in 100 cells; 30 min/90 min, time after transfer of HCV-infected cells to 37°C. Results, mean ± SD (n = 3). *, p < 0.05; **, p < 0.01 to reach hepatocytes. Therein, they encounter the hepatic extracellular matrix, and more specifically at the hepatocyte membrane, the glycocalyx. Here, we provide evidence that Synd-1, a glycocalyx component, plays a major role in HCV entry and infection of hepatocytes through a direct interaction with CD81. This occurs at an early infection stage, leading to virus internalization in Rab5-positive endosomal compartments. Synd-1 can thus be viewed as a CD81 cofactor of HCV entry.
Synd-1 is expressed at the surface of epithelial cells, exposed to the space of Disse in the liver (Stanford et al., 2009) internalization via clathrin-dependent endocytosis (Farquhar et al., 2012) . Synd-1 has been described as an HCV attachment factor (Shi et al., 2013) , and the concept that both HSPG and CD81 are important for HCV entry was highlighted by Wakita's group (Morikawa et al., 2007) . Our data therefore unravel a new link between HCV receptor molecules and the hepatocyte glycocalyx, namely, CD81
and Synd-1.
Our study shows that HCV infection downregulates Synd-1 and upregulates Xylt 2 expression, likely contributing to a major glycocalyx reshuffle within days. As obligate intracellular pathogens, viruses remodel their host cells for propagation, survival, and persistence.
The downregulation of entry factor(s) by HCV (Liu et al., 2009; Sainz et al., 2012) Liver HSPG (including Synd-1) harbour HS sugar chains that are highly sulfated at N-and 2-O-positions, with a higher sulfatesper-saccharide amount and a shorter length than those found in other tissues (Lyon, Deakin, & Gallagher, 1994; Toida et al., 1997 (Dietrich, Nader, & Straus, 1983) , but specificity in pattern recognition is highly stringent: for example, antithrombin only binds to specific pentasaccharides (Mosier, Krishnasamy, Kellogg, & Desai, 2012) . In all, the Synd-1 or CD81 complex can be viewed as a "landing (DL-101), and Synd-4 (5G9) were from Santa Cruz. Anti-Synd-1 (clone B-B4) fused to AlexaFluor®647 was from AbD Serotec. Horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit secondary antibodies were from Sigma-Aldrich. The monoclonal antibody 3G10
to HSPG neo-epitope (exposed after heparinases' digestion) was from Seikagaku, Japan. The monoclonal antibody to occludin (OC-3F10) was from CliniSciences (Nanterre, France). The anti-LDL-R monoclonal antibody IgG-C7 was from Research Diagnostics Institute.
Paraformaldehyde (16% aqueous solution) was from Electron Microscopy Sciences.
| Cells and viruses
PHHs were isolated from liver resections and cultivated as described (Pichard et al., 2006) . The isolation procedure complied with the ethical regulations imposed by French legislation on usage of surgical liver samples unused for diagnostic purpose and approved by the "Comité
Consultatif de Protection de Personnes dans la Recherche
Biomédicale" (Centre Léon Bérard, Lyon). Huh7.5 cells were a gift from Dr. Rice (Rockefeller University, NY, USA). HepG2c-CD81-IRF3(ΔN)-NS5A cell line (HepG2c-CD81) was established and cultivated as described (Jammart et al., 2013) . HepG2 parental cells were from ATCC® (HB-8065™). Cell lines were maintained in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 1X GlutaMAX, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 μg/ml streptomycin in 5% CO 2 -normoxia incubator at 37°C. HCV Japanese fulminant hepatitis-1 (JFH-1) stock preparation and titration were performed as reported (Wakita et al., 2005) .
| HCVcc particles generation
The plasmid containing the full-length JFH-1 genome (pJFH1) was provided by Dr Wakita (Tokyo, Japan). All subsequent procedures to produce viral particles (HCVcc) were described in (Jammart et al., 2013) .
| Highly viremic patient's serum characterization
A clinical study approval was obtained from the French AFSSAPS (agreement #B100128-40) and Ethics Committee (agreement #2010-008-2) in order to purify HCV virions from human plasmas.
Among several HCV-positive patients, we identified one highly viremic (1.24 × 10 7 IU/ml) and IFN-non responder patient. The density profile of the virions was assessed after ultracentrifugation on iodixanol isopycnic linear density gradients, as described (Nielsen et al., 2006) , and their replication potential in Huh7.5 cell cultures.
| Virus infectivity
Virus infectivity in culture supernatants was assessed as focus forming units (FFU/mL), counting HCV core foci.
| Pseudoparticles generation
Production of HCVpp or VSVGpp or pseudoparticles devoid of envelope glycoprotein (No Env pp), expressing GFP as the reporter gene, was achieved in 293 T cells, as described (Bartosch, Dubuisson, & Cosset, 2003) . These cells were grown in Dulbecco's modified Eagle's medium containing 10% fetal calf serum, 1X GlutaMAX, 1 mM sodium pyruvate, 100 U/ml penicillin, and 100 μg/ml streptomycin, supplemented with 1 mg/ml geneticin, in 5% CO 2 -normoxia incubator at 37°C.
| RNA quantification
Total intracellular RNA was extracted using TRIzol®, according to manufacturer's protocol. Samples were treated with DNAse prior to reverse transcription on 1 μg RNA, using High Capacity cDNA RT Kit Noise was corrected, and structural pixels corresponding to Synd-1 or CD81 signals were identified by applying a threshold to images in order to obtain a representative mask of Synd-1 and CD81. These masks were then used for conversion into binary images, from which Immuno-staining was achieved with secondary anti-rabbit coupled to DyLight®555 and anti-mouse coupled to AlexaFluor®647.
Imaging was performed using a Leica Confocal Spectral TCS SP5X microscope. 4.13 | Synd-1 detection Huh7.5 cell pellets were frozen at −80°C. After thawing, they were lysed in a buffer containing 1% Triton X-100 in 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 mM EDTA and proteases inhibitor cocktail (Roche). Cells were then left on ice for 1 hr. Lysates were then centrifuged at 8,000g for 20 min at 4°C, and 500 μl of each supernatant was incubated with antibodies to: Synd-1 (DL101 and H-174 ; 2 × 2.5 μg), CD81 (TS81), flotillin-1, HCV core (C7-50), or Synd-4 (5G9). After an overnight incubation at 4°C on a wheel, 50 μl of protein A/G Sepharose beads was added, and incubation was prolonged for 6 hr. Beads were then washed five times in lysis buffer and resuspended in Laëmmli buffer under reduced conditions.
4.11
Samples were loaded on 10% polyacrylamide gels, and proteins transferred on PVDF membranes were subsequently blotted with monoclonal anti-Synd-1 (DL101).
| In situ PLA
PHHs were seeded on collagen-coated coverslips placed in six-well plates. Two days later, they were infected with JFH-1-HCV (MOI 0.1) and maintained in supplemented William's E medium (Pichard et al., 2006) . 
| Statistical analyses
Data are means ± standard deviation of three independent experiments in triplicates, unless otherwise stated. All data were analyzed by analysis of variance and Tukey's post-hoc t test. Differences were considered significant when p < .05.
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